Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sophiris Bio Inc SPHS

Sophiris Bio Inc is a clinical-stage biopharmaceutical company. It focuses on the development of products for the treatment of urological diseases. The company's product portfolio includes topsalysin (PRX302), for the treatment of lower urinary tract symptoms of benign prostatic hyperplasia (BPH), as well as for the treatment of localized low to intermediate risk prostate cancer. Topsalysin is a genetically modified recombinant protein which is selectively activated by enzymatically active prostate-specific antigen (PSA), which is only present in the prostate, leading to localized cell death and tissue disruption without damage to neighboring tissue and nerves. Geographically all the operations of the company are functioned in the United States.


EXPM:SPHS - Post by User

Bullboard Posts
Comment by rythmanon Nov 08, 2013 12:38pm
152 Views
Post# 21889076

RE:RE:RE:FDA approves Medivation prostate cancer drug

RE:RE:RE:FDA approves Medivation prostate cancer drug
Right I agree, and it only costs about $7,000 a month for a prescription. Not really a SHS/SPHS deal killer.
For those concerned about the TSX listing, the symbol on Q is SPHS. It trades about 60,000 shares
a day on average. You will end up with the same number of shares only in US dollars.
I sold my non-registered shares for a capital loss, am considering buying SPHS in new year. Still, we have over a year before results are available.
rythman
Bullboard Posts